tradmap

PLSE Earnings Pulse Biosciences, Inc.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Revenue (annual)
$0 $709000 $1M 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Revenue
Net income (annual)
-$73M -$36M $0 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Net income

Quarterly results

Diluted EPS (quarterly)
-$2 -$1 $0 Q2 '21 Q3 '21 Q2 '22 Q3 '22
EPS
Revenue (quarterly)
$0 $217000 $434000 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Revenue
Net income (quarterly)
-$25M -$12M $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Net income

Reported EPS history

1–4 of 4
Q3 20222022-09-30-1.502022-11-1010-Q
Q2 20222022-06-30-1.022022-08-1010-Q
Q3 20222021-09-30-1.762022-11-1010-Q
Q2 20222021-06-30-1.292022-08-1010-Q

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.